In fiscal 2025, which ended Dec 31, 2025, Guardian Pharmacy Services, Inc. reported revenue of $1.4 billion. Net income was $49.2 million, a profit margin of 3.4%. Operating income came to $72.7 million, an operating margin of 5.0%. Over the twelve months ended Sep 30, 2026, revenue was $1.5 billion and net income was $74.8 million.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
|---|---|---|
| Revenue |
1,457
|
1,449
|
| Cost of revenue |
1,130
|
1,156
|
| Gross profit |
327
|
293
|
| Selling, general and administrative |
233
|
220
|
| Operating expenses |
233
|
220
|
| Operating income |
94
|
73
|
| Interest expense |
1
|
1
|
| Other non-operating income (expense) |
12
|
1
|
| Pretax income |
105
|
73
|
| Income tax |
29
|
24
|
| Net income |
75
|
49
|
| Other measures | ||
| Depreciation and amortization |
23
|
22
|
| EBITDA |
118
|
95
|
| Interest coverage |
145.28x
|
109.32x
|
| Margins | ||
| Gross margin |
22.45%
|
20.21%
|
| Operating margin |
6.46%
|
5.02%
|
| Pretax margin |
7.22%
|
5.07%
|
| Profit margin |
5.13%
|
3.40%
|
| EBITDA margin |
8.07%
|
6.56%
|
| Effective tax rate |
27.68%
|
33.32%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Retail-Drug Stores and Proprietary Stores (SIC 5912)
- Listed as
- GRDN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- GA
- Headquarters
- Atlanta, GA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1802255
- Former names
- Guardian Pharmacy Services, Inc. (until Sep 28, 2026); Guardian Pharmacy, LLC (until Jul 23, 2021)
Other Retail-Drug Stores and Proprietary Stores companies
- CVS HEALTH Corp CVS
- 111, Inc. YI
- Petmed Express Inc PETS
- Ridgetech Inc. RDGT
- TREES Corp (Colorado) CANN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.